(Q44238552)

English

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

scientific article published on 3 December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Gopal K Marathe

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Guy A Zimmerman

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Thomas M McIntyre

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

3 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

278

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3937-3947

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Pharmacogenomic considerations of the paraoxonase polymorphisms

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Biologically active oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Platelet-activating factor receptor: gene expression and signal transduction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Platelet-activating factor and related lipid mediators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Pralidoxime and l-lactate effects in vitro on the inhibition of acetylcholinesterase by paraoxon: pralidoxime does not confer superior protection.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Why plasma should not be used to study paraoxonase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Inflammatory Platelet-activating Factor-like Phospholipids in Oxidized Low Density Lipoproteins Are Fragmented Alkyl Phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Influence of dicarboxylic phosphatidylcholines on the stability and phase transition of phosphatidylcholine liposomes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211126200

21 January 2018

Identifiers

10.1074/JBC.M211126200

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44238552&oldid=2108843274"